(1 - 15 von 18
)
CEVEC and Généthon sign a collaboration agreement to develop...
pipelinereview.com
The agreement with Généthon is a strong endor…t of our CAP(R)GT system and represents a major step in the roll-out of our strategy to position our platform as the technology of choice for commercial production of lentiviral vectors for gene therapy applications," commented Frank Ubags, Chief Executive Officer of CEVEC …s GmbH.
CEVEC introduces CAP(R)Go expression system for scalable production...
www.eqs-news.com
... placing CEVEC at the leading edge of industrial protein manufacturing," commented Frank Ubags, Chief Executive Officer of CEVEC …s GmbH "The CAP(R) ...
CEVEC's CAP(R)GT sets a new standard through RCA-free production of...
www.eqs-news.com
"We have delivered superior results with the production of CAP(R)GT-derived adenoviral vectors," commented Frank Ubags, Chief Executive Officer of CEVEC …s GmbH. "The advantages in terms of safety and ... More information: www.CEVEC.com. Follow CEVEC on LinkedIn. Contact: ...
DGAP-News: CEVEC strengthens team to execute rapid growth strategy...
www.wallstreet-online.de
Frank Ubags, Chief Executive Officer of CEVEC …s GmbH, commented, "Following our focus on glycoproteins and gene therapy vectors
sortiert nach Relevanz / Datum